🇺🇸 FDA
Pipeline program

autologous adipose-derived mesenchymal stem cell transplantation

1690/QĐ-BYT

Phase 2 mab active

Quick answer

autologous adipose-derived mesenchymal stem cell transplantation for Aging Problems is a Phase 2 program (mab) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Aging Problems
Phase
Phase 2
Modality
mab
Status
active

Clinical trials